Clinical Trials Search at Vanderbilt-Ingram Cancer Center
Study of Avelumab-M3814 Combinations
Multiple Cancer Types
The main purpose of the study is to evaluate a safe, tolerable recommended Phase II dose (RP2D) and / or the maximum tolerated dose (MTD) of M3814 when given in combination with avelumab with and without radiotherapy in participants with selected advanced solid tumors.
Miscellaneous,
Phase I
I
Iams, Wade
NCT03724890
VICCPHI18160